Menu Close

Trending

Measuring the cost-effectiveness of vaccines targeting infectious diseases
Could your loyalty card help spot cancer? Study says yes
JP Morgan 2023 – Adi Hoess
Tackling ongoing staffing burnout rates through AI-enabled precision oncology
Ipsen’s rare disease drug palovarotene knocked back in EU

pruritus

chronic kidney disease

Market Access/ News/ News

Cara, Vifor get EU okay for drug to treat itching in dialysis patients

, , , , , , 0 Comment

Vifor Pharma and Cara Therapeutics’ Kapruvia has become the first drug to be approved in the EU to

X
Cara, Vifor get EU okay for drug to treat itching in dialysis patients
https://pharmaphorum.com/news/cara-vifor-get-eu-okay-for-drug-to-treat-itching-in-dialysis-patients/
Korsuva_image

Market Access/ News/ News

Cara’s Korsuva is first drug cleared for itching in dialysis patients

, , , , , , , 0 Comment

One of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease –

X
Cara’s Korsuva is first drug cleared for itching in dialysis patients
https://pharmaphorum.com/news/caras-korsuva-is-first-drug-cleared-for-itching-in-dialysis-patients/

Login

CONTINUE TO SITE >
X
Close in 10 seconds